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Abstract
Introduction: Mammographic density is a strong risk factor for breast cancer. Image acquisition technique varies
across mammograms to limit radiation and produce a clinically useful image. We examined whether acquisition
technique parameters at the time of mammography were associated with mammographic density and whether
the acquisition parameters confounded the density and breast cancer association.
Methods: We examined this question within the Mayo Mammography Health Study (MMHS) cohort, comprised of
19,924 women (51.2% of eligible) seen in the Mayo Clinic mammography screening practice from 2003 to 2006.
A case-cohort design, comprising 318 incident breast cancers diagnosed through December 2009 and a random
subcohort of 2,259, was used to examine potential confounding of mammogram acquisition technique parameters
(x-ray tube voltage peak (kVp), milliampere-seconds (mAs), thickness and compression force) on the density and
breast cancer association. The Breast Imaging Reporting and Data System four-category tissue composition
measure (BI-RADS) and percent density (PD) (Cumulus program) were estimated from screen-film mammograms at
time of enrollment. Spearman correlation coefficients (r) and means (standard deviations) were used to examine
the relationship of density measures with acquisition parameters. Hazard ratios (HR) and C-statistics were estimated
using Cox proportional hazards regression, adjusting for age, menopausal status, body mass index and
postmenopausal hormones. A change in the HR of at least 15% indicated confounding.
Results: Adjusted PD and BI-RADS density were associated with breast cancer (p-trends < 0.001), with a 3 to 4-fold
increased risk in the extremely dense vs. fatty BI-RADS categories (HR: 3.0, 95% CI, 1.7 - 5.1) and the ≥ 25% vs. ≤ 5% PD
categories (HR: 3.8, 95% CI, 2.5 - 5.9). Of the acquisition parameters, kVp was not correlated with PD (r = 0.04, p = 0.07).
Although thickness (r = -0.27, p < 0.001), compression force (r = -0.16, p < 0.001), and mAs (r = -0.06, p = 0.008) were
inversely correlated with PD, they did not confound the PD or BI-RADS associations with breast cancer and their
inclusion did not improve discriminatory accuracy. Results were similar for associations of dense and non-dense area
with breast cancer.
Conclusions: We confirmed a strong association between mammographic density and breast cancer risk that was
not confounded by mammogram acquisition technique.
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Introduction
Percent mammographic density represents the proportion
of stromal and epithelial tissue visible on a mammogram.
Mammographic density varies between women and is
influenced by age, body mass index (BMI), and some epi-
demiologic risk factors for breast cancer such as nulliparity
and late age at first birth [1,2]. Women in the highest cate-
gories of percent density (PD) are at three to five times
greater risk of breast cancer relative to those in the lowest
category, making it one of the strongest known risk factors
for breast cancer [3,4]. The associations with breast cancer
are consistent whether density is measured as a qualitative
trait (for example, American College of Radiology Breast
Imaging Reporting and Data System (BI-RADS) tissue
composition assessment) [5,6] or a quantitative trait (for
example, computer-assisted thresholding-based methods
such as Cumulus) [3,7-9].
Although a substantial number of investigations of
mammographic density and breast cancer have been
reported [3], the majority were conducted across multiple
institutions and consequently using different mammogra-
phy units. This increases the potential for variation in the
density estimates because of several parameters, including
the influence of image acquisition. The image acquisition
parameters consisting of compressed breast thickness,
compression force, x-ray tube voltage peak (kVp), milliam-
pere-seconds (mAs), and target-filter combination, where
applicable, vary across mammograms to limit radiation
and produce a clinically useful image. The kVp is set either
automatically when using the automated exposure control
(AEC) mode or by the technologist by using a reference or
look-up table. The mAs value (or, equivalently, the x-ray
production) is controlled by the AEC. The compression
paddle setting, determined by the technologist, depends
on the breast size as well as the patient’s tolerance to com-
pression force. Thus, we expect larger breasts to have lar-
ger compressed breast thicknesses. The kVp setting is a
positive function of compressed breast thickness. It is well
known that larger breasts are more apt to be composed of
adipose tissue. Therefore, we hypothesize that both com-
pressed breast thickness and kVp will be associated posi-
tively with non-dense area and inversely with PD. Dense
breast tissue has greater x-ray attenuation properties than
adipose tissue. Therefore, we expect the mAs value to
have a positive correlation with dense area and also with
PD. Firm or larger breasts (or both) require greater levels
of compression force to both spread out and separate the
breast tissue in order to maximize the image clarity. We
speculate that compression force, though more difficult to
connect, is associated positively with non-dense area and
inversely with PD.
Given the expected associations of these acquisition
parameters with mammographic density measures, we
further hypothesized that the acquisition measures
confound the density and breast cancer associations. But
no studies known to date have directly evaluated the influ-
ence of the different acquisition parameters on the density
and breast cancer association. Some studies, however,
have accounted for acquisition through calibration (that is,
normalizing the inter-image pixel value scale) but these
findings are mixed; some show that calibration results in
stronger mammographic density and breast cancer asso-
ciations [10,11], whereas others have shown that calibra-
tion does not improve these associations [12,13]. In this
report, we examine the association of the acquisition para-
meters with mammographic density measures and their
influence on the density and breast cancer association
within a prospective cohort study from a single large
breast practice, the Mayo Mammography Health Study
(MMHS) Cohort.
Materials and methods
Mayo Mammography Health Study eligibility
The MMHS prospectively enrolled patients scheduled for
a screening mammogram from October 2003 through
September 2006 at the Mayo Clinic in Rochester, MN.
The MMHS was approved by the Mayo Institutional
Review Board. Women were invited to take part if they
were at least 35 years old, residents of Minnesota, Iowa, or
Wisconsin (tri-state), and had no personal history of breast
cancer. Women scheduled for a diagnostic mammogram
(known or suspected breast cancer) were not eligible. Eli-
gible women were mailed an invitation packet consisting
of a study brochure, a consent form, a baseline question-
naire, and a permission request form to link to state
tumor registries. Out of 49,032 women initially invited,
10,149 were excluded for residence outside of the tri-state
area (1,698), mammogram not for screening purposes
(that is, a diagnostic mammogram) (6,383), and a personal
history of breast cancer (2,068). Of 38,883 eligible women,
19,924 provided written informed consented (51.2%
adjusted response rate) (Figure 1). Compared with non-
participants, participants were younger (11 months on
average) and more likely to have ever used post-menopau-
sal hormones (45% versus 33%), to have a first- or second-
degree family history of breast cancer (19% versus 16%),
more frequent mammograms (47% versus 38% had seven
or more mammograms since 1986), and a history of breast
biopsy (23% versus 20%) (Additional file 1).
Mayo Mammography Health Study questionnaire
All women were asked to complete a written question-
naire that covered mammogram screening behaviors;
menstrual and reproductive factors; surgeries of the
breast, ovaries, and/or uterus; use of hormone therapies;
medical history; family size and cancer history; use of
non-steroidal anti-inflammatory medications; use of
vitamins and complementary medicines; alcohol and
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cigarette use; physical activity; current weight and
weight history; race; and education. Height and weight
were also abstracted from the Mayo Clinic medical
record at the medical visit closest in time to each mam-
mogram collected for the study. To identify subjects
with prevalent cancer, the medical history section of the
questionnaire inquired of previous cancer diagnoses. A
total of 2,283 women in the cohort reported having had
at least one form of cancer (other than breast cancer)
prior to enrollment. This group is excluded for analyses
restricted to a ‘Healthy cohort’ (see Additional file 2 for
a listing of prior cancer types self-reported among
cohort members). Women with a prior diagnosis of
breast cancer were ineligible and excluded earlier from
the cohort.
Follow-up
Follow-up for cancer occurrence was performed annually
by using a combination of cancer registry data (passive
follow-up) and mailed follow-up (active follow-up).
Figure 1 Flow diagram of the subjects included in analyses in the Mayo Mammography Health Study.
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All women were linked to the Mayo Clinic Tumor Regis-
try to identify cases of cancer that had been diagnosed or
treated (or both) at the Mayo Clinic since enrollment. To
identify cancers external to the Mayo system, women who
lived in Minnesota, Iowa, or Wisconsin and had provided
written consent for linkage to external tumor registries
(99.7%) were linked to their respective state tumor
registries.
Active follow-up to obtain cancer and vital status was
conducted in 2009 and 2010 via mail and telephone from
women who had not been back to the Mayo Clinic within
12 months (thus, the medical record would not have cur-
rent cancer diagnoses) and either had moved outside Min-
nesota, Iowa, or Wisconsin (1,755 women, 8.8%) or did
not grant consent for registry linkage (62 women, 0.3%).
Telephone follow-up was attempted on non-responders to
the mailed contact. Thus, women who were eligible for
active follow-up were contacted each year unless they
were seen at the Mayo Clinic in the prior 12 months.
Some women, then, could have been actively followed in
one year but not the other. Active follow-up using all pos-
sible methods was successful for 83.1% in 2009 and 78.4%
in 2010. By using both passive follow-up through the
registries where possible and active contact by our staff,
we have been able to collect cancer occurrence data on
98.8% of our cohort through 2010 (96,483 person-years).
Person-years of follow-up were computed as the
amount of time since completion of the enrollment
mammogram to subsequent events that differed depend-
ing upon whether the woman remained a resident of the
tri-state area (and thus would be passively reported to us
by the relevant state tumor registry) or moved outside.
Women who resided in Minnesota, Iowa, or Wisconsin
over the period were censored in the following order: (a)
at the date of diagnosis with breast cancer, (b) at the date
of death, or (c) on 17 December 2009. Women who
moved out of these three states were censored in the fol-
lowing order: (a) at the date of diagnosis with breast can-
cer, (b) at the date of last response to cohort follow-up,
(c) at the date last seen at the Mayo Clinic, or (d) at the
date last known to reside in Minnesota, Iowa, or
Wisconsin.
Case-cohort design
We used the case-cohort design, in which all incident
breast cancer cases that occurred in the at-risk cohort dur-
ing the follow-up and a random sample of approximately
10% of those in the cohort (n = 2,259, plus 39 who later
became cases) were selected to conduct the main analyses.
We chose this design to permit prospective collection and
analysis of the mammograms and risk factor data begin-
ning at the start of the project. This design reduced the
costs and time associated with obtaining mammograms
and PD estimates on every woman in the cohort.
Mammogram acquisition, retrieval, digitization, and
density estimation
All mammograms at the Mayo Clinic over the time of the
study were performed on one of 12 Hologic (LoRad)
screen-film mammography systems (Hologic, Inc., Bed-
ford, MA, USA) using either molybdenum (Mo)/Mo or
Mo/rhodium (Rh) target-filter materials. Image acquisition
parameters vary across mammograms to limit radiation
and produce a clinically useful image. The compressed
breast thickness (distance between the compression paddle
and breast support surface) is set by the technician and is
dependent upon the breast size and the patient’s tolerance.
In tandem, the compression force is defined by the paddle
adjustment. Breast compression is used to achieve uniform
breast thickness and spread the breast tissue to improve
image quality. Accuracy of the measurement of thickness
was within ± 5 mm; furthermore, the paddle tilt, which
depends on breast size, paddle size, and compression
force, showed tilt deflections of less than 1 cm when a
known standard for evaluation was used. The mAs value
varies due to the AEC. The AEC limits the exposure while
producing a useful image and is dependent upon the
breast size, breast composition, and sensor location(s).
The AEC mode used for the images acquired in this study
was primarily AutoFilter mode. In AutoFilter mode, the
x-ray unit uses a short prepulse exposure to determine the
lowest kVp selection that delivers a total exposure time of
below 2 seconds or 200 mAs. In this mode, the minimum
kVp selection is 25 kVp used with a Mo filter. The kVp
selection rises with increased tissue attenuation up to
30 kVp, where the Mo filter is exchanged with an Rh filter.
When the maximum kVp is reached (31 or 32 kVp), the
mAs value may exceed 200 as needed. For very thin
breasts, the AEC mode used was AutoTime, where the
kVp was manually set at 23 kVp with Mo filter. KVp was
tested annually with a control limit of 5.
All image acquisition parameters were manually
abstracted by our staff from the printed screen-film mam-
mogram: the compressed breast thickness (in millimeters),
compression force (in pounds), x-ray tube voltage peak
(kVp), milliampere-seconds (mAs), and filter. Note that
when kVp is 30 or above, the filter is automatically Rh. In
our data, very few individuals had a kVp of 30 or above
requiring an Rh filter. Thus, the target-filter combination
was limited and therefore was not considered in the
analysis.
For all cases and women in the subcohort, we obtained
and digitized one view from the enrollment screen-film
mammogram (2003 to 2006). Screen-film mammograms
were digitized on the Array 2905 laser digitizer (Array Cor-
poration, Roden, The Netherlands), which has 50-μm (lim-
iting) pixel spacing with 12-bit grayscale bit depth. PD was
estimated by a single trained programmer (F-FW) from the
craniocaudal mammogram view of the non-cancerous
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breast of cases and the left breast of controls. All images
were scrubbed of identifying information and re-oriented
so that all images were presented consistently despite the
side evaluated. Thus, the reader was blinded to cancer sta-
tus. Batch files were composed of both cases and controls,
and a 5% repeat set of images was included within each
batch file to assess reliability. Percent mammographic den-
sity (dense area divided by total area, times 100%) was esti-
mated by the programmer by using a computer-assisted
thresholding program, Cumulus [7]. Briefly, two thresholds
are set by the programmer; one separates the breast from
the background and the other separates dense from non-
dense tissue. In the batch files examined for this study, our
reader consistently demonstrated high reliability (intraclass
correlation of greater than 0.93).
In addition to estimating the semi-quantitative estima-
tion of density described above, we obtained the clinical
BI-RADS four-category tissue composition assessment
corresponding to the enrollment mammogram from the
Mayo Clinic electronic medical record. The BI-RADS tis-
sue composition has been routinely estimated on all
screening mammograms at the Mayo Clinic since mid-
1996. Mayo Clinic attending radiologists classified each
mammogram into one of four categories as defined in the
BI-RADS lexicon over this period (American College of
Radiology, third edition): (a) the breast is almost entirely
fat; (b) there are scattered fibroglandular densities; (c) the
breast tissue is heterogeneously dense, which may lower
the sensitivity of mammography; and (d) the breast is
extremely dense, which could obscure a lesion on mam-
mography. These ratings convey the relative possibility
that a lesion may be obscured in mammography. All four
mammogram views (craniocaudal and mediolateral obli-
que for ipsilateral and contralateral sides) contribute to
the assessment of BI-RADS composition. In our study, we
used the estimates that experienced radiologists assessed
in the clinical setting. These radiologists did not systemati-
cally assess BI-RADS composition for this study, but this
rating has shown adequate interobserver reliability [14].
Statistical analyses
We first verified that the randomly sampled subcohort
represented the full cohort by comparing basic demo-
graphic and clinical factors between the subcohort and all
other cohort members (Table 1). Next, we compared these
factors between breast cancer cases and the members of
the subcohort by using t tests for continuous variables and
chi-square tests for categorical variables. We estimated
hazard ratios (HRs) and their 95% confidence intervals by
using Cox proportional hazards regression to describe the
association between the two mammographic density mea-
sures and breast cancer. Age was used as the time scale in
the Cox model; age at enrollment was used as the starting
point, and follow-up age was defined as age at breast can-
cer diagnosis for cases and age at last known follow-up for
members of the subcohort. The case-cohort design was
accounted for by applying sampling weights to subjects
selected for the subcohort [15]. In addition to estimating
the HRs, we performed tests for trend and computed the
C-statistic from the Cox proportional hazards model to
measure the degree to which mammographic density
could discriminate risk between breast cancer cases and
the other members of the subcohort. We compared the
relative risk of breast cancer between groups of women
classified into quartiles of PD based on values observed in
the subcohort. Women in the lowest density category
served as the reference group. Analyses of dense and non-
dense area were conducted similarly.
Two additional analyses were performed to ensure the
integrity of our findings. First, to ensure that prevalent
cancers did not influence our results, we performed the
above analyses excluding 2,283 members of the cohort
who had a cancer diagnosis other than breast cancer prior
to baseline enrollment. Second, we performed analyses of
BI-RADS density and breast cancer within the entire
cohort of 19,924 women to compare with results from the
case cohort. Because the PD measure was not available on
the entire cohort, we were unable to compare results for
this density measure.
Data for mAs, thickness, and compression force were
divided into quartiles. kVp data were not normally distrib-
uted, and 55% of values were at a standard value of 25.
Thus, this variable was categorized into a three-level ordi-
nal variable. To examine the association of acquisition
parameters with mammographic density, we estimated the
mean and standard deviations (SDs) of PD, dense area,
and non-dense area by categories of the four acquisition
parameters. We also calculated Spearman correlation coef-
ficients between acquisition parameters and density mea-
sures. Next, we examined the degree to which inclusion of
each of the acquisition parameters contributed to the
breast cancer association in the presence of the measure
of mammographic density, and the amount that each of
these acquisition parameters individually, and all measures
combined, changed the HR estimates from the original
models. A change in the HR estimates of 15% or greater
would provide evidence of confounding. To determine the
degree to which these parameters influenced the predic-
tion of breast cancer risk, we also computed C-statistics
for the proportional hazards regression models that
included the acquisition parameters as covariates. Similar
analyses were conducted by using dense area and non-
dense area as the endpoints.
All analyses were carried out with the SAS software sys-
tem (SAS Institute Inc., Cary, NC, USA). All reported P
values are two-sided, and comparisons were adjusted for
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variables found to be significantly associated with density,
including age, menopausal status, post-menopausal hor-
mone use, and BMI.
Results
Of the 19,924 women in the MMHS cohort, 59 had a pre-
valent breast cancer (defined as within 60 days post-enroll-
ment), leaving 19,865 eligible women for these analyses.
Incident cases included 318 breast cancers diagnosed
before 31 December 2009, and the subcohort consisted of
2,298 women randomly sampled from the entire cohort.
Of the subcohort, 39 became cases and 2,259 were unaf-
fected (Table 1 and Figure 1).
The average follow-up times from enrollment mammo-
gram to diagnosis or last follow-up were 2.4 years (SD =
1.7) for cases and 5.0 years (SD = 0.9) for the subcohort.
As shown in Table 1, the mean age of cases at enrollment
was 61.8 years, which was slightly higher than among
members of the cohort (58.0 years) or subcohort (58.0
years). BMI was similar in all three groups. Cases were
more likely than women in either the cohort or subco-
hort to be post-menopausal. Cases were less likely to
report having never used post-menopausal hormone
therapy (46.5%) than women in either the subcohort
(49.7%) or cohort (50.3%).
Table 1 also displays the means and SDs of the den-
sity estimates and the four acquisition parameters. Mean
(SD) PD and dense area were higher among cases
(19.1% (13.7%) and 2,622 mm2 (1,939), respectively)
than controls (17.6% (14.1%) and 2,333 mm2(1,841),
respectively). Of the acquisition parameters, only mAs
values showed a greater mean (SD) among cases (161.0
(49.4)) compared with controls (157.9 (49.5)).
We first confirmed the mammographic density and
breast cancer association in our study. As expected, both
mammographic density measures, PD and BI-RADS,
were associated with future risk of breast cancer (P trend
< 0.001) (Table 2). Women with a PD of greater than
25.1% were 3.8 (95% CI 2.5 to 5.9) times more likely to
develop breast cancer during the follow-up period than
women with a PD of 0% to 5.0%. Similarly, women in the
highest BI-RADS category (Extremely dense) compared
with the lowest BI-RADS category (Almost entirely fat)
were 3.0 (95% CI 1.7 to 5.1) times as likely to develop
breast cancer during the follow-up period. When only
invasive breast cancers were considered (n = 199, data
not shown), risk estimates were somewhat strengthened
for the PD and breast cancer association (HR 5.1, 95% CI
3.0 to 8.4 for the highest versus lowest category of PD)
but not for the BI-RADS association (HR 2.7, 95% CI 1.5
to 5.0 for the highest versus the lowest level of BI-RADS
density). The two additional analyses to evaluate the pos-
sible influence of prevalent cancers and the case-cohort
(versus full cohort) design on our results showed no
marked difference from the main analyses (Additional
file 3).
Table 1 Demographic and risk factor distributionsa of the Mayo Mammography Health Study cohort (2003 to 2006)
Analysis groups
Cases, Mean or N (SD/%)b Subcohort, Mean or N (SD/%) Eligible cohort, Mean or N (SD/%)
Number 318 2,259 19,865c
Age, years 61.8 (11.2) 58.0 (12.2) 58.0 (12.2)
Body mass index, kg/m2 28.9 (6.9) 28.1 (6.5) 28.2 (6.4)
Post-menopausal hormone use
Current 61 (19.2%) 445 (19.4%) 3,554 (17.9%)
Former 85 (26.7%) 505 (22.0%) 4,561 (23.0%)
Never 148 (46.5%) 1,143 (49.7%) 9,986 (50.3%)
Unknown 24 (7.6%) 205 (8.9%) 1,764 (8.9%)
Post-menopausal 252 (79.3%) 1,592 (69.3%) 13,627 (68.6%)
Imaging parameters
Number 254 1,910
Percent density 19.1 (13.7) 17.6 (14.1)
Dense area, mm2 2,622 (1,939) 2,333 (1,841)
Non-dense area, mm2 13,232 (6,702) 13,460 (7,198)
Milliampere-seconds 161.0 (49.4) 157.9 (49.5)
X-ray tube voltage peak, kVp 26.2 (1.7) 26.1 (1.5)
Thickness, mm 53.9 (13.3) 53.2 (12.7)
Compression force, pounds 24.7 (6.1) 24.9 (5.6)
aReported at enrollment; b39 women overlap between cases and subcohort; c59 women were deleted for breast cancers occurring within the first two months
after enrollment. They are included in the full cohort but excluded from analyses in this paper. SD, standard deviation.
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Next, we examined the association and correlation
between PD, dense area, and non-dense area and the four
acquisition parameters. Table 3 shows the mean (SD) den-
sity by categories of acquisition technique. mAs, thickness,
and compression were inversely associated with PD, as
reflected in the mean differences and correlations (r =
-0.03 (P = 0.60), -0.25 (P < 0.001), and -0.14 (P = 0.02),
respectively, for the cases and r = -0.06 (P = 0.008), -0.27
(P < 0.001), and -0.16 (P < 0.001), respectively, for the sub-
cohort members). The strongest association was seen
across quartiles of thickness (mean PD of 23.3% in the
lowest quartile of thickness versus 13.0% in the highest
thickness quartile). kVp did not show strong evidence of
an association with PD across categories. Mean dense
area, however, increased across levels of kVp and mAs and
decreased across levels of thickness and compression
force. Non-dense area increased across levels of all four
acquisition parameters, and the largest correlation was
seen for thickness and non-dense area (r = 0.41, P < 0.001
among cases; r = 0.35, P < 0.001 among non-cases).
The strongest correlations among acquisition para-
meters themselves were observed between thickness with
mAs (r = 0.70 for cases and subcohort) and kVp (r = 0.72
for cases and r = 0.70 for subcohort). The smallest correla-
tions were seen between compression and the other acqui-
sition parameters (mAs, r = 0.10 for cases and r = 0.13 for
controls; kVP, r = 0.11 for cases and r = 0.10 for controls;
thickness, r = 0.001 for cases and r = 0.03 for controls).
This was not entirely surprising since kVp is a function of
breast thickness and mAs values are influenced by breast
size (correlated with thickness) and composition.
Table 4 presents the evaluation of acquisition technique
on the association between age and BMI-adjusted density
and risk of breast cancer. Four parameters were evaluated
singly and in combination: x-ray tube kVp, mAs, com-
pressed breast thickness, and compression force. Inclusion
of these parameters did not alter the strength of the asso-
ciation between age and BMI-adjusted PD and breast can-
cer or alter the association of BI-RADS density with breast
cancer. For example, each millimeter increase in thickness
was associated with only a 1.08-fold increased risk of
breast cancer (95% CI 0.92 to 1.26) in the analyses of PD
and breast cancer risk. The other three parameters showed
similar non-statistically significant associations with breast
cancer. The discriminatory capacity of the model after
inclusion of any of these four parameters, as estimated by
the C-statistic, was not improved for the PD-breast cancer
association (0.63 or 0.64 for all models, including the
model with all four parameters included) or for the BI-
RADS and breast cancer association (C-statistic 0.62 for
all models, including the model with all four parameters
included) (Table 4).
Similar analyses were conducted by examining the asso-
ciation of adjusted dense area and non-dense area with
breast cancer. Like the results with PD and BI-RADS,
inclusion of these four acquisition parameters, singly or in
combination, did not alter the association between dense
area and breast cancer or non-dense area with breast can-
cer (Table 5). Finally, there was no evidence of interactions
between PD and acquisition parameters on breast cancer
risk (mAs P = 0.67, kVp P = 0.77, thickness P = 0.95, and
compression force P = 0.93).
Table 2 Association between mammographic density estimates on the enrollment (screen-film) mammograms and risk
of breast cancer in the Mayo Mammography Health Study cohort (2003 to 2009)
Number of cases (total n =
272)a
Number of person-years (total n =
9,958.8)b, c
Multivariate adjusted hazard ratio
(95% CI)c
Percent density
0.0-5.0 43 2,193.8 1.00 (Ref.)
5.1-15.0 79 2,746.1 2.02 (1.37, 2.97)
15.1-25.0 59 2,386.4 2.03 (1.32, 3.11)
25.1+ 91 2,632.5 3.80 (2.46, 5.86)
P trend < 0.001
BI-RADS lexicon
1: Almost entirely fat 44 2,181.6 1.00 (Ref.)
2: Scattered fibroglandular
densities
111 3,904.5 1.61 (1.13, 2.29)
3: Heterogeneously dense 94 3,210.1 2.02 (1.38, 2.95)
4: Extremely dense 23 662.7 2.96 (1.73, 5.07)
P trend < 0.001
Analyses adjusted for age, menopausal status, post-menopausal hormone use, and body mass index. aForty-six cases were excluded from the original 318 cases
for the following reasons: digital mammogram (13), implants (12), and inability to read density (21). Percent density and BI-RADS (Breast Imaging Reporting and
Data System) analyses were restricted to the same women. bThree hundred two in the subcohort were excluded for the following reasons: digital mammogram
(123), implants (62), and inability to read density (117). Percent density and BI-RADS analyses were restricted to the same women (272 cases and 1,957 in the
subcohort).
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Discussion
Within a prospective screening cohort at a single institu-
tion, we confirmed the association between age and BMI-
adjusted mammographic density and breast cancer by
using a subjective clinical measure or a semi-quantitative
estimate. We showed that the acquisition technique was
associated with percent and area density measures. How-
ever, the mammographic density and breast cancer asso-
ciations were not materially influenced by adjustment for
parameters of mammogram acquisition, suggesting that
the density and breast cancer association is robust, at least
in the screen-film setting.
Our estimates of the association between PD and breast
cancer are comparable to those of other cohort studies
that used computer-assisted quantitative estimates of per-
cent mammographic density [3,4]. Our estimate that
women with greater than 25% density are at 3.8-fold
increased risk of breast cancer is similar to those of 3.5 to
4.4 times in nested case-control studies using similar den-
sity categories. Because these earlier studies used mammo-
grams from multiple institutions with variations in type of
mammography machine manufacturer and processing
technique whereas the MMHS used mammograms from a
single institution with the same machines and protocols,
this report also suggests that this variability in the PD
measure has not markedly biased previous reports.
We evaluated the association of mammogram acquisi-
tion on percent and area density measures. Our findings
of positive associations between compressed breast thick-
ness, compression force, and kVp with non-dense area
were expected, given the associations between these mea-
sures and breast size. Because larger breasts generally
have greater adipose tissue content, they also tend to
have lower percent or proportion of density compared
with smaller breasts with the same amount of dense area.
As such, our findings of inverse associations of PD with
thickness and compression were consistent. Along this
line of reasoning, we also anticipated an inverse associa-
tion of kVp with PD but found no evidence for this. We
noted, instead, positive associations of kVp with both
dense and non-dense breast area. Although somewhat
difficult to interpret, this implies that larger breasts have
relatively larger amounts of both adipose and dense tis-
sue than smaller breasts, as observed in the projection
Table 3 Associationa of density estimates (percent density, dense area, and non-dense area) and categoriesb of the
four acquisition parameters






Mean SD Mean SD Mean SD
Percent density 0.09 (0.15)d 0.04 (0.07)d 17.1 13.8 17.3 14.8 19.0 14.3
Dense area 0.28 (< 0.001)d 0.16 (< 0.001)d 2,070 1,603 2,404 1,864 2,987 2,238
Non-dense area 0.20 (0.002)d 0.16 (< 0.001)d 12,349 6,393 14,386 7,512 15,405 8,289
Quartile 1 Quartile 2 Quartile 3 Quartile 4
mAs 9-126 127-173 174-194 194-371
Mean SD Mean SD Mean SD Mean SD
Percent density -0.03 (0.60) -0.06 (0.008) 18.4 14.3 18.4 14.9 17.1 13.9 16.3 13.3
Dense area 0.14 (0.02) 0.09 (< 0.001) 1,958 1,481 2,432 1,843 2,415 1,867 2,534 2,086
Non-dense area 0.24 (< 0.001) 0.25 (< 0.001) 10,906 6,034 13,412 7,284 14,214 7,091 15,404 7,571
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Thickness, mm 6-45 46-54 55-62 62-94
Percent density -0.25 (< 0.001) -0.27 (< 0.001) 23.3 16.5 17.7 13.2 15.7 12.7 13.0 11.3
Dense area -0.01 (0.89) -0.12 (< 0.001) 2,512 1,846 2,425 1,857 2,261 1,798 2,113 1,844
Non-dense area 0.41 (< 0.001) 0.35 (< 0.001) 10,211 6,210 13,604 7,142 14,152 6,632 16,236 7,494
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Compression force, pounds 6.6-21 22-24 25-28 28-49
Percent density -0.14 (0.02) -0.16 (< 0.001) 20.5 15.1 18 14.5 16.9 14.1 14.2 11.6
Dense area -0.01 (0.88) -0.02 (0.39) 2,360 1,761 2,258 1,695 2,407 1,999 2,283 1,880
Non-dense area 0.26 (< 0.001) 0.31 (< 0.001) 10,859 5,945 12,788 6,749 14,153 6,759 16,536 8,160
aMean and SD of density by categories are estimated using the subcohort only. Correlation coefficients estimated on cases and subcohort separately. bQuartiles
were used where appropriate. The distribution of voltage peak (kVp) was highly skewed and was categorized into three levels. cOwing to missing acquisition
parameters, 18 cases and 47 controls that were included in the analyses depicted in Table 2 are not included here. dCorrelation coefficients for kVp are based on
the three categories and not continuous measures. mAs, milliampere-seconds; SD, standard deviation.
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Table 4 Evaluation of acquisition parameters on the association between adjusted mammographic densitya estimated from enrollment (screen-film)
mammograms and risk of breast cancer in the Mayo Mammography Health Study cohort (2003 to 2009)
Models with addition of acquisition parameters




mAs Thickness Compression All 4
acquisitionparameters




HRb(95% CI) HRb(95% CI) HRb(95% CI) HRb(95% CI) HRb(95% CI) HRb(95% CI)
0% to 5.0% 42 2,071.0 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)



























kVp - 1.04 (0.87,
1.25)
- - - 1.01 (0.82, 1.24)
mAs - - 1.04 (0.89,
1.21)
- - 1.00 (0.79, 1.26)
Thickness, mm - - - 1.08 (0.92,
1.26)
- 1.06 (0.83, 1.35)
Compression,
pounds
- - - - 0.93 (0.82,
1.06)
0.94 (0.82, 1.07)
C-statistic 0.64 0.64 0.64 0.63 0.64 0.63
BI-RADS
1 41 2,082.8 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)



























kVp - - 1.07 (0.89,
1.28)
- - - 1.06 (0.84, 1.33)
mAs - - 1.06 (0.91,
1.23)
- - 1.05 (0.85, 1.29)
Thickness, mm - - - 1.07 (0.92,
1.25)
- 0.99 (0.78, 1.27)
Compression,
pounds
- - - - 0.92 (0.81,
1.05)
0.92 (0.80, 1.05)
C-statistic 0.62 0.62 0.62 0.62 0.62
aAnalyses adjusted for age, menopausal status, post-menopausal hormone use, and body mass index. bHazard ratios (HRs) corresponding to milliampere-seconds (mAs), thickness, and compression refer to a 1
standard deviation (SD) change in the respective parameter (SD: mAs = 49.5, thickness = 12.7, compression = 5.6). HRs corresponding to voltage peak (kVp) are based on a tri-level ordinal variable (22-25, 26-27, 28-
32). Owing to missing acquisition parameters, 18 cases and 47 controls that were included in the analyses depicted in Table 2 are not included here. BI-RADS, Breast Imaging Reporting and Data System; CI,














Table 5 Evaluation of acquisition parameters on the association between adjusteda dense area and non-dense area estimated from enrollment (screen-film)
mammograms and risk of breast cancer in the Mayo Mammography Health Study cohort (2003 to 2009)
Models with addition of acquisition parameters




mAs Thickness Compression All 4 acquisition
parameters










HRb (95% CI) HRb (95% CI)
0 to 985 53 2,373.0 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)









































0 to 985 58 2,397.1 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)







































aAnalyses adjusted for age, menopausal status, post-menopausal hormone use, and body mass index. bHazard ratios (HRs) corresponding to milliampere-seconds (mAs), thickness, and compression refer to a 1
standard deviation (SD) change in the respective parameter (SD: mAs = 49.5, thickness = 12.7, compression = 5.6). HRs corresponding to voltage peak (kVp) are based on a tri-level ordinal variable (22-25, 26-27, 28-














image. We also found a positive association between mAs
values and dense area, as originally hypothesized, but also
a positive association with non-dense area and a very
small but inverse association with PD. kVp and mAs
appear to influence the absolute density measures to a
greater extent than the ratios, but this needs to be con-
firmed in other studies.
We had hypothesized that these acquisition parameters
may confound the association between mammographic
density measures and breast cancer risk. However, inclu-
sion of these parameters, alone or in combination, did not
influence the association between density and risk of
breast cancer. Also, their inclusion did not improve the
discriminatory capacity of the statistical models. There-
fore, in the context of screen-film mammography and the
density measures considered in this report (that is, PD, BI-
RADS, dense area, and non-dense area), these acquisition
parameters appear not to introduce meaningful variation
reflected in the density and breast cancer associations.
The lack of confounding of the density and breast can-
cer association by thickness was not consistent with
studies that suggest that volumetric density, which is
dependent on compressed thickness, is more informative
than PD and area measures [11]. Our focus on the cov-
ariate-adjusted (including BMI) density phenotypes likely
explains the discrepancy. In fact, models examining PD
and acquisition parameters with breast cancer that did
not adjust for BMI found significant associations of all of
the acquisition parameters related to thickness - that is,
thickness (HR 1.20, 95% CI 1.05 to 1.38), mAs (HR 1.17,
95% CI 1.03 to 1.34), and kVp (HR 1.19, 95% CI 1.01 to
1.41) - with breast cancer. However, similar to models
adjusting for BMI, the parameter estimates for the asso-
ciations of density with breast cancer and the discrimina-
tion capability (C-statistics) did not materially change for
models with or without the acquisition technique.
Our findings need to be considered in the context of
the study design of our cohort. The mammograms
included in our study were from a single institution.
Therefore, the mammograms in this study are less likely
to include variation from x-ray unit manufacturer, film-
screen combination, and film processing conditions than
would mammograms in a study that included mammo-
grams collected from multiple institutions. This may limit
the generalizability of our findings. In studies with greater
variation in mammogram manufacturers and acquisition
techniques, it is possible that controlling for these para-
meters may have a greater impact. This hypothesis needs
to be tested in studies that collect mammograms from
multiple sources.
We know of no other studies that have evaluated the
direct influence of acquisition technique parameters on
the density and breast cancer association. However, some
studies have been designed to account for these
parameters by using calibrated approaches [10-13]. The
calibrated approach seeks to nullify uncertainties (or varia-
tion) introduced by the acquisition technique differences
by producing standardized data, often with the aim of
making comparisons with PD. The evaluation is indirect
because the calibrated measure in the comparison is not
necessarily PD and not a one-to-one comparison of the
same metric such as PD derived from two data representa-
tion (that is, from calibrated and raw data). Similar to our
findings, some of these studies show that the density and
breast cancer association is not strengthened when
accounting for the acquisition technique differences when
using calibration approaches [12,13]. Because calibration is
a newer approach for assessing density and the calibrated
density measures are normally not the same metric as PD
(or BI-RADS), it is not clear at this time whether the inclu-
sion of the technique parameters in general is not impor-
tant or whether the calibration techniques require further
modifications. However, our findings reinforce and
emphasize the robustness of the existing area-based per-
cent breast density measures (that is, PD and BI-RADS), at
least on digitized screen-film mammography.
Strengths of our study include the prospective nature
(allowing evaluation of mammograms prior to cancer), the
estimation of density by two separate methods (a semi-
quantitative method and a subjective clinical measure),
and the ability to systematically compare responders and
non-responders in our study by using existing clinical
databases. BI-RADS density did not differ substantially
between participants and non-participants in the MMHS
cohort, and establishing the cohort within one breast
screening practice allowed us to reduce other sources of
variation, including x-ray equipment (manufacturer) cali-
brated similarly over this period and the use of one digiti-
zer. A limitation of our study was that BI-RADS density
was estimated by numerous readers over time, but this
reflects the true clinical experience and how this measure
would be used in practice. Owing to a lack of variability
within our population, our analyses of acquisition did not
include the target-filter acquisition technique. Finally, our
investigations reflect only acquisition influence on density
estimates from screen-film mammograms and on mam-
mograms from one institution only. Similar studies need
to be conducted on images acquired from multiple institu-
tions and on full-field digital mammography.
Conclusions
Results from the MMHS cohort confirm a strong associa-
tion between mammographic density and risk of breast
cancer which was not materially influenced by variability in
image acquisition parameters. Based upon similar risk esti-
mates for the mammographic density/breast cancer asso-
ciation, our data suggest that estimation of the association
between breast density and breast cancer is not improved
Olson et al. Breast Cancer Research 2012, 14:R147
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by including acquisition parameters. Mammographic den-
sity remains a robust breast cancer risk factor that merits
consideration for integration into the clinical practice to
inform risk assessment and possible intervention.
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